▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #3643 by analyst upside · 2026-08-13
HIMS
Hims & Hers Health, Inc.
Healthcare · Market Cap $7B · P/E 0x
ANALYST PRICE TARGET
+4.0%
implied upside to consensus target
Current Price $29.97
Consensus Target $31.15
Bull Target $42.0
Bear Target $23.0
Analysts Covering 13
ANALYST CONSENSUS - HOLD
Strong Buy
2
Buy
1
Hold
10
Sell
0
52-Week Low $13.74
52-Week High $65.3
YTD Return -10.3%
FUNDAMENTALS
Market Cap $7B
P/E Ratio (TTM) N/A
Forward P/E 23.8x
EPS (TTM) $-0.64
PEG Ratio 2.15
Dividend Yield N/A
Revenue (TTM) $2.6B
Profit Margin -5.5%
52-WEEK RANGE
52-Week Low $13.74
52-Week High $65.3
Current Price $29.97
Bear Target $23.0
Bull Target $42.0
● Now $29.97 ● Target $31.15
TRADING DATA
Avg Volume 17.2M
YTD Return -10.3%
Analyst Count 13
Consensus Hold
Upside to Target +4.0%
Last Updated 2026-08-13

ANALYST SUMMARY

Hims & Hers Health, Inc. (HIMS) is currently trading at $29.97 with a Wall Street consensus price target of $31.15, implying potential upside of 4.0% over the next 12 months. 13 analysts currently cover HIMS, with a consensus rating of Hold - 23% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $42.0, while the most cautious has a target of $23.0.

HIMS operates in the Healthcare sector with a market capitalisation of $7B. The stock is down 10.3% year-to-date and is currently trading near the lower end of its 52-week range of $13.74 – $65.3.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

CHE +2.0%
Chemed Corporation
$7B · P/E 27.2x · Hold
UHS +12.5%
Universal Health Services, Inc.
$10B · P/E 7.0x · Hold
TGTX +40.8%
TG Therapeutics, Inc.
$8B · P/E 18.2x · Buy
ATR +27.8%
AptarGroup, Inc.
$8B · P/E 24.0x · Buy
QGEN +7.1%
Qiagen N.V.
$9B · P/E 21.7x · Buy

RECENT ANALYST CALLS

Upgrade/downgrade history for HIMS, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Barclays - Reiterated
Overweight → Overweight 2026-06-18 Building track record
B of A Securities - Reiterated
Neutral → Neutral 2026-05-26 Building track record
Truist Securities - Reiterated
Hold → Hold 2026-05-22 Building track record
B of A Securities - Reiterated
Neutral → Neutral 2026-05-19 Building track record
B of A Securities - Reiterated
Neutral → Neutral 2026-05-13 Building track record
Citigroup - Reiterated
Neutral → Neutral 2026-05-12 Building track record
JP Morgan - Reiterated
Overweight → Overweight 2026-05-12 43% win rate (7 calls)
BTIG reit
Neutral → Neutral 2026-05-12 38% win rate (8 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
39
out of 100
Coverage depth
20/30
Consensus clarity
17/30
Vote unanimity
0/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →